US$ 27.48
glp-1 ras drugs medications like Ozempic, Wegovy and Mounjaro are changing diabetes and weight management, but they aren't recommended during pregnancy or while nursing. The current recommendation is to stop before conception and discuss GLP-1 RAs, Other Agents, Underused
Description
Mounjaro is superior for blood sugar control

[12] Sndergaard CS, et al

Wegovy is approved for use in adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition

The most prevalent factors employers take into consideration for GLP-1 drug coverage for obesity care include: Obesity as a risk factor for chronic conditions and associated costs67% Drug shortages47% Impact/effectiveness of cost-control mechanisms47% Existing coverage through government programs40% Long-term costs33% Patient and prescriber demand33%

It does not prove anything in isolation
